Funding for Research on Psychedelics Is on th...

In this episode of Science Quickly, we start with a quick update on the Ebola outbreak surging in parts of Africa. Host Rachel Feltman is then joined by Scientific American’s senior desk editor for life science Andrea Thompson to discuss what rising temperatures mean for the FIFA ...  Show more

In this episode of Science Quickly, one of SciAm’s Young American Scientists, biologist Jaye Gardiner, explores how common viral infections may raise cancer risk—not just through genetic mutations but by reshaping the body’s “extracellular matrix” of molecules that support cells ...  Show more

As interest and support for psychedelic research grows, scientists share their hopes for the future. Learn more about your ad choices. Visit megaphone.fm/adchoices 

As companies join the hunt, can the field of mind-altering synthetic substances stay true to its original pioneering spirit of wonder, curiosity and connection? Learn more about your ad choices. Visit megaphone.fm/adchoices 

Psychedelic researchers are engaged in heated debate over whether the mind-altering effects of the drugs are necessary for realizing their therapeutic potential. Learn more about your ad choices. Visit megaphone.fm/adchoices 

James Gallagher reports on a psychedelic renaissance; a new wave of research testing hallucinogenic drugs like magic mushrooms to treat mental health conditions.There’s genuine excitement and some early encouraging evidence. A manufacturer tells James that in five years’ time, it ...  Show more